Strumento inattivo

Altre lingue Paxman AB (publ) Nasdaq Stockholm

Azioni

SE0009806284

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Press release from PAXMAN AB’s 2024 Annual General Meeting	23/05
Paxman AB Appoints Karen Giddings Clakely to the Board	23/05
PAXMAN publishes its interim report for Q1 2024	23/05
Paxman AB Reports Earnings Results for the First Quarter Ended March 31, 2024	23/05
Paxman publishes the company’s annual report for 2023	26/04
The shareholders of PAXMAN AB (publ) (”the Company”) are hereby invited to attend the Annual General Meeting on Thursday 23 May 2024 at 12:00 CEST.	19/04
See Redeye's interview with CEO Richard Paxman	23/02
Record year for Paxman!	23/02
Paxman AB Reports Earnings Results for the Full Year Ended December 31, 2023	15/01
Paxman's CEO Richard Paxman in a company presentation at Stora Aktiedagen in Stockholm	29/11
See CEO Richard Paxman presents at Redeye Life Science Day 2023 – 23 November	27/11
See Redeye's interview with CEO Richard Paxman	17/11
PAXMAN publishes its interim report for Q3 2023	17/11
Paxman AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	17/11
Richard Paxman OBE, CEO of Paxman, will join Redeye Life Science Day 2023	10/11
PAXMAN Announces that US Centers for Medicare and Medicaid Services (CMS) continues to support scalp cooling but decreases rate for 2024	07/11
PAXMAN Announces Palmetto GBA Approves First Local Coverage Determination for Scalp Cooling Therapy	03/10/23
PAXMAN Announces Palmetto GBA Approves First Local Coverage Determination for Scalp Cooling Therapy	03/10/23
See Redeye's interview with CEO Richard Paxman	25/08/23
PAXMAN publishes its interim report for Q2 2023	24/08/23

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Paxman AB (publ) Nasdaq Stockholm

Azioni

SE0009806284

Altre lingue

Filtri